EUVIMEDEUVIMED entdecken
Crossref

Anti-factor B antibodies in atypical hemolytic uremic syndrome

Priyanka Khandelwal, Shreesha Nambiar, Rahul Saini, Savita Saini, Poonam Coshic, Aditi Sinha, Pankaj Hari, Jayanth Kumar Palanichamy, Arvind Bagga iD

Pediatric Nephrology · 2024

DOI: 10.1007/s00467-024-06284-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, 2024. Verfasst von Priyanka Khandelwal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Pediatrics, ICMR Center for Advanced Research in Nephrology, All India Institute of Medical Sciences, New Delhi…. Hauptthemen laut MEDLINE: Atypical Hemolytic Uremic Syndrome, Glomerulonephritis, Membranoproliferative, Glomerulonephritis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Biotechnology, Government of India (IN).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The etiology of atypical hemolytic uremic syndrome (aHUS) is unknown in 30-40% of patients. Anti-factor B (FB) antibodies are reported in C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN), though not in aHUS. METHODS: We screened patients < 18-year-old from cohorts of aHUS and C3G/idiopathic IC-MPGN. Anti-FB IgG antibodies were measured by ELISA and confirmed by Western blot. Normative levels were based on antibody levels in 103 healthy blood donors. RESULTS: Prevalence of anti-FB antibodies was 9.7% (95% CI 6.1-14.5%; n = 21) in 216 patients with aHUS, including 11.5% (95% CI 6.4-18.5%; n = 14) in anti-FH associated aHUS and 11.8% (95% CI 4.4-23.9%; n = 6) in patients without a definitive genetic or autoimmune etiology. Patients with significant genetic variants did not show anti-FB antibodies. In patients with concomitant anti-FB and anti-FH antibodies, median anti-FH titers were higher (11,312 AU/mL vs. 4920 AU/mL; P = 0.04). Anti-FB antibody titer correlated with disease severity (hemoglobin and platelets; P < 0.05), declined following plasma exchange and increased during relapse. While 4/64 patients with C3G (6.3%) and 1/17 with IC-MPGN showed anti-FB antibodies, titers were higher in aHUS (544.8 AU/mL vs. 1028.8 AU/mL; P = 0.003). CONCLUSION: Anti-FB antibodies are present in 6-10% of patients with aHUS and C3G/IC-MPGN, with higher titers in the former. The diagnostic and therapeutic implication of anti-FB antibodies in aHUS needs confirmation and further studies. The study shows propensity for autoantibody generation and co-existence of multiple risk factors for aHUS in Indian children.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atypical Hemolytic Uremic SyndromeGlomerulonephritis, MembranoproliferativeGlomerulonephritisChildHumansAdolescentAutoantibodiesImmunoglobulin GAntilymphocyte SerumComplement Factor H

Stichwörter der Autor:innen

AutoantibodiesC3 glomerulopathyComplement pathwayThrombotic microangiopathy

Substanzen

AutoantibodiesImmunoglobulin GAntilymphocyte SerumComplement Factor H

Autor:innen und Institutionen

  • Division of Nephrology, Department of Pediatrics, ICMR Center for Advanced Research in Nephrology, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Transfusion Medicine and Blood Bank, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
  • Division of Nephrology, Department of Pediatrics, ICMR Center for Advanced Research in Nephrology, All India Institute of Medical Sciences, New Delhi, India. arvindbagga@hotmail.com.

ORCID-Profile: Arvind Bagga

Förderung

  • Indian Council of Medical Research
  • Department of Biotechnology, Government of India (IN)

Zitieren

APA

Khandelwal, P., Nambiar, S., Saini, R., Saini, S., Coshic, P., Sinha, A., Hari, P., Palanichamy, J. K., & Bagga, A. (2024). Anti-factor B antibodies in atypical hemolytic uremic syndrome. Pediatric Nephrology. https://doi.org/10.1007/s00467-024-06284-x

Vancouver

Khandelwal P, Nambiar S, Saini R, Saini S, Coshic P, Sinha A, et al. Anti-factor B antibodies in atypical hemolytic uremic syndrome. Pediatric Nephrology. 2024. doi:10.1007/s00467-024-06284-x

BibTeX
@article{Khandelwal2024,
  author = {Khandelwal, Priyanka and Nambiar, Shreesha and Saini, Rahul and Saini, Savita and Coshic, Poonam and Sinha, Aditi and Hari, Pankaj and Palanichamy, Jayanth Kumar and Bagga, Arvind},
  title = {Anti-factor B antibodies in atypical hemolytic uremic syndrome},
  journal = {Pediatric Nephrology},
  year = {2024},
  doi = {10.1007/s00467-024-06284-x}
}
Kostenlos starten →